Provided by Tiger Trade Technology Pte. Ltd.

Polaryx Therapeutics, Inc.

8.91
-7.0900-44.31%
Post-market: 8.47-0.4408-4.95%19:52 EST
Volume:188.81K
Turnover:1.68M
Market Cap:421.83M
PE:- -
High:17.20
Open:17.20
Low:7.35
Close:16.00
52wk High:48.91
52wk Low:7.35
Shares:47.34M
Float Shares:47.34M
Volume Ratio:6.45
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.8876
ROE:--
ROA:--
PB:79.58
PE(LYR):-10.04

Loading ...

Company Profile

Company Name:
Polaryx Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
11
Office Location:
South Tower,140 E Ridgewood Avenue,Suite 415,Paramus,New Jersey,United States
Zip Code:
07652
Fax:
- -
Introduction:
- -

Directors

Name
Position
Alex Yang
Chair of the Board and Chief Executive Officer
Charles Ryan
Independent Director
Francis A. Braun
Independent Director
G. Michael Landis
Chief Financial Officer and Director
Mitchel Berger
Independent Director

Shareholders

Name
Position
Alex Yang
Chair of the Board and Chief Executive Officer
G. Michael Landis
Chief Financial Officer and Director
Andrew O
Chief Investment Officer
Lisa L. Bollinger
Chief Medical Officer
Minsu Kang
Director of Regulatory and Clinical Affairs
Shrijay Vijayan
Chief Scientific and Business Development Officer
Wuxin Zhu
Chief Chemistry, Manufacturing and Controls Officer